Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06143813

Precision Treatment of Lumbar Spine Surgery Through Advanced Nerve Root Blockade

The overall purpose of the study is to investigate whether selective spinal nerve root blocks can improve diagnostics of radiculopathy due to lumbar disc herniation (LDH), foraminal stenosis (FS), and recess stenosis (RS), and hence identify the patients that will benefit from surgical intervention.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aarhus University Hospital

Aarhus C, 8000, Denmark

Location status: Recruiting

Location contact

David Kocemba, MD

CONTACT

[email protected]

Mikkel Rasmussen, MD

CONTACT

[email protected]

About this study

The study is designed as a prospective randomized controlled trial, using a two-group stratified block-randomization, evaluating the effect of adding the outcome of a diagnostic SNRB to surgical decision-making. Stratification will be based on the study site. Block size will be 4, 6, or 8 and in random order.

All patients referred to our departments with suspected radiculopathy and radiological evidence of root compression are eligible for inclusion. Patients will be randomized to either standard care or SNRB after the consultation. Results of the SNRB will be available to the surgeon before deciding finally whether to operate or not. Hence, the intervention adds the outcome of the diagnostic SNRB to the shared surgical decision-making.

Study outline:

Baseline:

Demographics, Oswestry Disability Index, Eq5D, SF-36, NRS-LP, and NRS-BP will be recorded

1-month follow-up after surgery: Oswestry Disability Index, Eq5D, SF-36, NRS-LP, and NRS-BP will be recorded

3-months follow-up after surgery: Oswestry Disability Index, Eq5D, SF-36, NRS-LP, and NRS-BP will be recorded

12-months follow-up after surgery: Oswestry Disability Index, Eq5D, SF-36, NRS-LP, and NRS-BP will be recorded

Randomization:

Using RedCap patients will be randomized to receive a SNRB as part of the pre-operative workup or to direct operation.

SNRB-procedure:

At Aarhus University, the SNRB will be performed using CT-guidance; at Private Hospital Moelholm, the SNRB procedure will be guided by fluoroscopy. Drugs used are omnipaque (0,2 ml), betamethasone (0,5 ml) and bupivacain (0,5 ml)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18 years old
  • Suspected lumbar radiculopathy persistent ≥ 8 weeks
  • Radiological evidence of lumbar nerve root compression (herniated disc, recess stenosis, foraminal stenosis)

Exclusion criteria

  • Prior lumbar spine surgery
  • Mental illness
  • Language barrier in Danish
  • Severe physical co-morbidity
  • Known allergies to medicine used in the study
  • Pregnant
  • Plans to move abroad during the next 12-months

Treatment and study plan

Selective nerve root block (SNRB)

Diagnostic Test

CT/Fluoroscopy guided nerve root block

Other names: Transforaminal nerve root block

Primary outcomes

  1. Minimum clinically important difference (MCID)

    Time frame: 3 months after surgery/decision not to operate

    Difference in mean change on numerical rating scale for leg pain (NRS-LP) 3 months after surgery. The margin of non-inferiority will be set to = 1.6 points. Comparison will be made between patients in the SNRB group and patients in the control group surgery.

Secondary outcomes

  1. Leg pain

    Time frame: 3 months after surgery/decision not to operate

    Difference in proportions reaching 1.6 points on NRS-LP 3 months after surgery/decision to not to operate. Comparison will be made between the SNRB group and the standard of care group.

  2. Back pain

    Time frame: 3 months after surgery/decision not to operate

    Mean change in numerical rating scale for back pain (NRS-BP) 3 months after surgery/decision to not to operate. Comparison will be made between the SNRB group and the standard of care group.

  3. SF-36 (Short form 36)

    Time frame: 3 months after surgery/decision not to operate

    SF-36 3 months after surgery/decision to not to operate. Comparison will be made between the SNRB group and the standard of care group.

  4. EQ5D (EuroQol 5D)

    Time frame: 3 months after surgery/decision not to operate

    EQ5D 3 months after surgery/decision to not to operate. Comparison will be made between the SNRB group and the standard of care group.

  5. ODI

    Time frame: 3 months after surgery/decision not to operate

    Oswestry Disability Index (ODI) 3 months after surgery/decision to not to operate. Comparison will be made between the SNRB group and the standard of care group.

  6. Subanalysis

    Time frame: 3 months after surgery

    Fraction of patients not reaching minimum clinically important difference (MCID) on the numerical rating scale for leg pain (NRS-LP) 3 months after surgery (MCID NRS-LP = 1.6 points). Comparison will be made between patients in the SNRB group who underwent surgery and patients in the control group that underwent surgery.

Study contacts

Contact information is provided by the study sponsor or research team.

David Kocemba, MD

CONTACT

[email protected]

+45 23882198

Mikkel Rasmussen, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • Private Hospital Moelholm

Registry information

Acronym: PLAN

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Nov 22, 2023
Registry last updated
May 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.